Jackson ImmunoResearch

Antibody Description	Unconjugated	NEW DyLight 405 A=400, E=421	Coumarin AMCA A=350, E=450	Cyanine Cy2 A=492, E=510	DyLight 488 A=493, E=518	Fluorescein FITC A=492, E=520	DyLight 549 A=555, E=568	Cyanine Cy3 A=550, E=570	Rhodamine TRITC A=550, E=570	Rhodamine Red-X RRX A=570, E=590	Texas Red TR A=596, E=620	DyLight 594 A=591, E=616	DyLight 649 A=652, E=670	Cyanine Cy5 A=650, E=670	Biotin-SP (long spacer)	Horseradish Peroxidase	Alkaline Phosphatase
Goat Anti-Bovine IgG (H+L)	€ 89 / 2.0 mg 101-005-003	€ 144 / 2.0 mg 101-475-003	€ 126 / 2.0 mg 101-155-003	€ 137 / 2.0 mg 101-225-003	€ 144 / 2.0 mg 101-485-003	€ 110 / 2.0 mg 101-095-003	€ 144 / 2.0 mg 101-505-003	€ 137 / 2.0 mg 101-165-003	€110 / 2.0 mg 101-025-003	€ 110 / 2.0 mg 101-295-003	€ 130 / 2.0 mg 101-075-003	€ 144 / 2.0 mg 101-515-003	€ 144 / 2.0 mg 101-495-003	€ 137 / 2.0 mg 101-175-003	€ 135 / 2.0 ml 101-065-003	€ 135 / 2.0 ml 101-035-003	€ 171 / 1.0 ml 101-055-003
Goat Anti-Bovine IgG (H+L) ML* (min X Arm Hms, Hu, Ms, Rat Sr Prot)	116 / 1.5 101-005-165	193 / 1.5 101-475-165	168 / 1.5 101-155-165	183 / 1.5 101-225-165	193 / 1.5 101-485-165	147 / 1.5 101-095-165	193 / 1.5 101-505-165	183 / 2.0 101-165-165	147 / 1.5 101-025-165	147 / 1.5 101-295-165	183 / 1.5 101-075-165	193 / 1.5 101-515-165	193 / 1.5 101-495-165	183 / 1.5 101-175-165	181 / 1.5 101-065-165	181 / 1.5 101-035-165	216 / 1.0 101-055-165
Goat Anti-Bovine IgG, Fc fragment specific																177 / 2.0 101-035-008
Rabbit Anti-Bovine IgG (H+L)	123 / 2.0 301-005-003	144 / 1.5 301-475-003	126 / 1.5 301-155-003	137 / 1.5 301-225-003	144 / 1.5 301-485-003	116 / 1.5 301-095-003	144 / 1.5 301-505-003	137 / 1.5 301-165-003	116 / 1.5 301-025-003	116 / 1.5 301-295-003	130 / 1.5 301-075-003	144 / 1.5 301-515-003	144 / 1.5 301-495-003	137 / 1.5 301-175-003	163 / 1.5 301-065-003	163 / 1.5 301-035-003	176 / 1.0 301-055-003


♦		Warning: BSA and dry milk may contain IgG which will react with this antibody. Use of BSA and/or dry milk to block or dilute this antibody may increase background and/or reduce secondary antibody titer.
*		ML=Multiple Labeling (see Multiple Labeling for an explanation.)